Clinical Trials in Portland

Showing 81-100 of 10,048 trials

Sleep and Circadian Mechanisms of Non-dipping Blood Pressure

NCT03558893

This study will be the first to distinguish the relative contributions of sleep, circadian and behavioral mechanisms to the non-dipping BP profile in Black adults and will lay the groundwork for optimizing therapies dependent on mechanisms, such as targeting sleep, targeting circadian rhythmicity, or targeting behaviors, and raising the possibility that ideal therapy for hypertension (HTN) may differ by race. This research will ultimately help to improve health and survival in black populations with HTN.

HypertensionCardiovascular Risk Factor

Oregon Health and Science University30 participantsStarted Dec 2018

Portland, Oregon, United States

RECRUITING< 1 mile

Clinical Procedures to Support Research in ALS

NCT03489278

The purpose of the Clinical Procedures To Support Research (CAPTURE) study is to utilize information collected in the medical record to learn more about a disease called amyotrophic lateral sclerosis (ALS) and related disorders.

Amyotrophic Lateral SclerosisALS-Frontotemporal DementiaPrimary Lateral Sclerosis+1 more

University of Miami1,200 participantsStarted Feb 2018

Irvine, California, United States • Palo Alto, California, United States • San Francisco, California, United States +8 more locations

Sleep and Circadian Mechanisms of Non-dipping Blood Pressure

Clinical Procedures to Support Research in ALS

Find Trials by Condition in Portland

Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery

A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia

PALbociclib CoLlaborative Adjuvant Study

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Axicabtagene Ciloleucel

Neuropsychological and Behavioral Testing in Younger Patients With Cancer

A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

A Study of AZD3470, a PRMT5 Inhibitor, Given as Monotherapy and in Combination in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors

An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström Macroglobulinemia

Paresthesia-Free Fast-Acting Subperception (FAST) Study

Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy

Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes

Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma

Culturally Centering Medications for Opioid Use Disorder With American Indian and Alaska Native Communities